Who Owns XILIO THERAPEUTICS INC (XLO)? -- Institutional Holders (2026-06-30)
30 institutions reported holding $32.6M of XILIO THERAPEUTICS INC (XLO) in SEC 13F filings for 2026-06-30. Largest institutional holders: Bain Capital Life Sciences Investors, LLC ($6.4M), GILEAD SCIENCES, INC. ($6.2M), ORBIMED ADVISORS LLC ($5.7M), Frazier Life Sciences Management, L.P. ($4.0M), Stonepine Capital Management, LLC ($2.2M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | Bain Capital Life Sciences Investors, LLC | $6.4M | 664,021 | Hold |
| 2 | GILEAD SCIENCES, INC. | $6.2M | 650,389 | Hold |
| 3 | ORBIMED ADVISORS LLC | $5.7M | 592,300 | New |
| 4 | Frazier Life Sciences Management, L.P. | $4.0M | 422,505 | Hold |
| 5 | Stonepine Capital Management, LLC | $2.2M | 225,994 | Added |
| 6 | VANGUARD GROUP INC | $1.9M | 201,111 | Added |
| 7 | Sio Capital Management, LLC | $1.5M | 152,464 | Hold |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.1M | 111,541 | New |
| 9 | Merck & Co., Inc. | $1.0M | 105,982 | Hold |
| 10 | RENAISSANCE TECHNOLOGIES LLC | $614,586 | 64,153 | Added |
| 11 | MORGAN STANLEY | $545,619 | 56,954 | Trimmed |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $374,174 | 39,055 | Added |
| 13 | CITADEL ADVISORS LLC | $248,601 | 25,950 | New |
| 14 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $168,072 | 17,544 | New |
| 15 | TWO SIGMA INVESTMENTS, LP | $139,332 | 14,544 | New |
| 16 | Velan Capital Investment Management LP | $136,850 | 14,285 | Hold |
| 17 | GSA CAPITAL PARTNERS LLP | $130,000 | 13,590 | Trimmed |
| 18 | STATE STREET CORP | $127,519 | 13,311 | Hold |
| 19 | PRELUDE CAPITAL MANAGEMENT, LLC | $111,128 | 11,600 | New |
| 20 | BlackRock, Inc. | $83,892 | 8,757 | New |
| 21 | Steward Partners Investment Advisory, LLC | $6,840 | 714 | New |
| 22 | BARCLAYS PLC | $1,102 | 115 | New |
| 23 | Key Financial Inc | $565 | 59 | Hold |
| 24 | JONES FINANCIAL COMPANIES LLLP | $262 | 29 | New |
| 25 | UBS Group AG | $134 | 14 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30